A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo.
about
Survivors Remorse: antibody-mediated protection against HIV-1.Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerGlycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive ImmunizationDevelopment of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.Key gp120 Glycans Pose Roadblocks to the Rapid Development of VRC01-Class Antibodies in an HIV-1-Infected Chinese DonorStructure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site.Molecular Architecture of the Cleavage-Dependent Mannose Patch on a Soluble HIV-1 Envelope Glycoprotein Trimer.Germline-targeting immunogens.Antigenic landscape of the HIV-1 envelope and new immunological concepts defined by HIV-1 broadly neutralizing antibodies.Differential induction of anti-V3 crown antibodies with cradle- and ladle-binding modes in response to HIV-1 envelope vaccination.HIV antibodies for treatment of HIV infection.Structural principles controlling HIV envelope glycosylation.The glycan-mediated mechanism on the interactions of gp120 with CD4 and antibody: Insights from molecular dynamics simulation.Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages.Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies
P2860
Q30238730-C2063969-C375-438F-94AD-4D2574015DBEQ33786447-53E97625-CCBD-40A7-A66F-B35BC504547DQ34555891-E832CC90-8DB0-4E1A-A5FC-3440E23D3893Q36081789-8962617F-9094-4903-AB7A-F49648AEDDFEQ36736392-0C03553C-6DEE-4775-A7A1-73622D6EF464Q36888400-DD25E4C9-CC69-4644-91DC-166B0ECC1224Q37409244-8B8C3389-4210-4B0F-9F0B-E454D65C7C4FQ38290294-44A948D5-C5DD-42C5-9E0D-C374BD4233FAQ38764547-49F8776B-4BB2-4BA6-AFD3-86C80613C04AQ38862338-BC3B4E9E-F192-4A49-9014-896E236D6223Q38968180-572F23DE-2298-4426-9AC4-C080F41B9217Q39108716-430933C5-7AD9-4114-BB73-47A79215629BQ39211319-05ED73BC-C8C7-42C2-91EA-4C6142542B85Q47736276-78C7EA46-12F1-4D65-9140-033FC2ACC402Q50116524-642E9F92-0F06-48F3-9450-DA86167829EBQ53689028-C6BFF18D-E30A-4F3C-AF73-700DCD7823B0Q57003103-B942CBC1-89A0-4968-8A56-E227F935DCC8
P2860
A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A New Glycan-Dependent CD4-Bin ...... rts Pressure on HIV-1 In Vivo.
@ast
A New Glycan-Dependent CD4-Bin ...... rts Pressure on HIV-1 In Vivo.
@en
type
label
A New Glycan-Dependent CD4-Bin ...... rts Pressure on HIV-1 In Vivo.
@ast
A New Glycan-Dependent CD4-Bin ...... rts Pressure on HIV-1 In Vivo.
@en
prefLabel
A New Glycan-Dependent CD4-Bin ...... rts Pressure on HIV-1 In Vivo.
@ast
A New Glycan-Dependent CD4-Bin ...... rts Pressure on HIV-1 In Vivo.
@en
P2093
P2860
P50
P1433
P1476
A New Glycan-Dependent CD4-Bin ...... rts Pressure on HIV-1 In Vivo.
@en
P2093
Ariel Goldenthal
Cassie Liu
Florian Klein
Johannes F Scheid
John P Moore
Joshua A Horwitz
Klara Velinzon
Lilian Nogueira
Louise Scharf
Michael S Seaman
P2860
P304
P356
10.1371/JOURNAL.PPAT.1005238
P577
2015-10-30T00:00:00Z